⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7514666 | 1.00 | — | — | |
| SCHEMBL19716039 | 1.00 | — | — | |
| SCHEMBL8576503 | 1.00 | — | — | |
| SCHEMBL1752718 | 0.82 | — | — | |
| SCHEMBL15960839 | 0.82 | — | — | |
| SCHEMBL7810859 | 0.82 | — | — | |
| SCHEMBL21388498 | 0.75 | L3MBTL1 (0.42) | — | |
| SCHEMBL19716121 | 0.74 | — | — | |
| SCHEMBL8522492 | 0.74 | ATM (0.43) | — | |
| SCHEMBL19301763 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013016387-A1 | CORROSION-INHIBITING LUBRICANT AND METHODS THEREFOR | MCCREERY DAVID (US) | 2013-01-31 | — | — | WO | claimed |
| US-20240199541-A9 | PROCESSES TO PRODUCE BRIVARACETAM | SUZHOU PENGXU PHARMATECH CO. LTD. (CN) | 2024-06-20 | — | — | US | disclosed |
| EP-3302441-B1 | PROCESSES TO PRODUCE BRIVARACETAM | SUZHOU PENGXU PHARMATECH CO LTD (CN) | 2023-12-13 | — | — | EP | disclosed |
| US-11673862-B2 | Processes to produce brivaracetam | SUZHOU PENGXU PHARMATECH CO. LTD. (CN) | 2023-06-13 | — | — | US | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-11225655-B2 | Bi-functional complexes and methods for making and using such complexes | NUEVOLUTION A/S (DK) | 2022-01-18 | — | — | US | disclosed |
| EP-3540059-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | Nuevolution A/S (DK) | 2019-09-18 | — | — | EP | disclosed |
| US-20190152909-A1 | PROCESSES TO PRODUCE BRIVARACETAM | ESTEVE QUIMlCA S.A. (ES) | 2019-05-23 | — | — | US | disclosed |
| US-20190152908-A1 | PROCESSES TO PRODUCE BRIVARACETAM | ESTEVE QUIMlCA S.A. (ES) | 2019-05-23 | — | — | US | disclosed |
| US-10221134-B2 | Processes to produce brivaracetam | ESTEVE QUIMICA S.A. (ES) | 2019-03-05 | — | — | US | disclosed |
| EP-3302441-A1 | PROCESSES TO PRODUCE BRIVARACETAM | Suzhou Pengxu Pharmatech Co., Ltd. (CN) | 2018-04-11 | — | — | EP | disclosed |
| WO-2016191435-A1 | PROCESSES TO PRODUCE BRIVARACETAM | WANG PENG (US) | 2016-12-01 | — | — | WO | disclosed |
| US-20130281324-A1 | BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2013-10-24 | — | — | US | disclosed |
| WO-2013072825-A1 | PHTALAZINONE DERIVATIVES AS MPEGS -1 INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2013-05-23 | — | — | WO | disclosed |
| WO-2013038308-A1 | SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS AS mPGES-1 INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2013-03-21 | — | — | WO | disclosed |
| US-20100286442-A1 | NOVEL METHOD FOR PREPARING PREGABALIN | KAIST (KR) | 2010-11-11 | — | — | US | disclosed |
| US-20100286014-A1 | LOW PH POST-CMP RESIDUE REMOVAL COMPOSITION AND METHOD OF USE | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2010-11-11 | — | — | US | disclosed |
| EP-0675123-B1 | Cyclopropane derivatives and method of preparing the same | AJINOMOTO KK (JP) | 2001-02-21 | — | — | EP | disclosed |
| EP-0845454-A1 | Method for the production of optically active cyclopropane derivatives | Ajinomoto Co., Inc. (JP) | 1998-06-03 | — | — | EP | disclosed |
| EP-0675123-A1 | Cyclopropane derivatives and method of preparing the same | Ajinomoto Co., Inc. (JP) | 1995-10-04 | — | — | EP | disclosed |